A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis

Journal of Internal Medicine

Volumn 240, Issue 2, 1996, Pages 85-92

  Luomanmaki K ^a   Grankvist, S ^b   Hallert, C ^c   Jauro, I ^d   Ketola, K ^e   Kim, H C ^f   Kiviniemi, H ^e   Koskivirta, H ^e   Sorskog L ^d   Vilkko, P ^e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Norköping Hospital   (Sweden)

^d PFIZER INC   (United States)

^e R W Johnson Medical School ^*

^f ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Dalteparin; Deep vein thrombosis (DVT); Low molecular weight heparin (LMWH); Marder score; Unfractionated heparin (UFH); Venography

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARTIAL THROMBOPLASTIN TIME; PHLEBOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 9544233577     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.18845000.x     Document Type: Article

References (14)

1. Prandoni P, Leasing AWA, Büller HR, Carta M, Cogo A, Vigo M, et al. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet 1992; 339: 441-5.
2. Lindmarker P, Holmström M, Granqvist S, Johnsson H, Lockner D. Comparison of once daily subcutaneous dalteparin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis. Thromb Haemost 1994; 72(2): 186-90.
3. Hull RD, Raskob GE, Pineo GF, Green D, Trowbridge AA, Elliott G, et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992; 326: 975-82.
4. Holmström M, Berglund G, Granqvist S, Bratt G, Törnebohm E, Lockner D. Dalteparin once or twice daily in the treatment of deep vein thrombosis of the leg. Thromb Res 1992; 67: 49-55.
5. Étude Multicentrique. Traitment des thromboses veineuse profondes constituées. Étude comparative d'un fragment d'heparine de bas poids molécaire (dalteparin) administrée par voie sous-cutanée et de l'heparine standard administrée par voie intraveineuse continué. Rev Medicine Interne 1989; 10: 375-81.
6. A Collaborative European Multicenter Study. A randomized trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. Thromb Haemost 1991; 65: 251-6.
7. Simonneau G, Charbonnier B, Decousus H, Planchon B, Ninet J, Sie P, et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Arch Intern Med 1993; 153: 1541-6.
8. Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surs 1972; 104: 134-44.
9. Marder VJ, Soulen RL, Atichartakarn VM, Budzynski AZ, Parulekar S, Kim JR, et al. Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J Lab Clin Med 1977; 89: 1018-29.
10. Bratt G, Åberg W, Johansson M, Törnbohm E, Granqvist S, Lockner D. Two daily subcutaneous injections of dalteparin as compared with intravenous standard heparin in the treatment of deep vein thrombosis (DVT). Thromb Haemost 1990; 64: 506-10.
11. Alhenc-Gelas M, Jestin-Le Guernic C, Vitoux JF, Kher A, Aiach M, Feissinger JN for the Fragmin Study Group. Adjusted versus fixed doses of the low-molecular-weight heparin Fragmin in the treatment of deep vein thrombosis. Thromb Haemost 1994; 71: 698-702.
12. Lagerstedt C, Olsson CG, Fagher B, Norgren L, Tengborn L, Recurrences and late sequelae after first-time DVT. Relationship to initial signs. Phlebology 1995; 8: 62-7.
13. Lensing AW, Prins M, Koopman M, Büller H. Which heparin for proximal deep-vein thrombosis? (Letter). Lancet 1992; 540: 311-2.
14. Olsson CG, Adolfsson P, Lagerstedt C. Anticoagulant therapy of DVT outside hospital. Third International Symposium on Anticoagulant, Antithrombotic and Thrombolytic Drugs, Boston, MA, USA (in press).